– Cognizant aplicará IA generativa para mejorar el descubrimiento de fármacos para clientes farmacéuticos con NVIDIA BioNeMo

La experiencia en IA y la industria de Cognizant, combinadas con la plataforma de IA generativa NVIDIA BioNeMo, crean una base sólida para mejorar los resultados en los sectores de la salud y las ciencias biológicas

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.